A. O. Smith stock has lagged behind other industrial stocks over the past year and analysts remain cautious about its prospects.
While Bio-Techne stock has underperformed the broader market over the past year, analysts remain moderately bullish about its prospects.
The healthcare sector has had a mixed year, yet Solventum shareholders might feel as though they drew the short straw.
Jack Henry & Associates stock has underperformed the Nasdaq over the past year, but analysts remain moderately bullish about its prospects.
Jack Henry & Associates stock has underperformed the Nasdaq over the past year, but analysts remain moderately bullish about its prospects.
BlackRock is trimming roughly 200 positions even as the asset management giant continues to deliver strong inflows, earnings growth, and expanding margins.
Microsoft is fed up with weak performance from Xbox, so much so that it is likely to continue major layoffs — and maybe even a spinoff — in the coming weeks.
TSMC's biggest strength may be that its customers are also its competitors.
Cathie Wood’s aggressive buying signals strong confidence in SpaceX, but investors must decide whether Elon Musk’s ambitious AI vision can ultimately justify the company’s lofty valuation.
Burry added to his position in Adobe as shares fell to multi-year lows.